Mandatory notification of trade
Oslo 27.09.2012 - CEO of Bionor Pharma ASA, Steen Krøyer, has yesterdaypurchased 100,000 Bionor shares at a price of NOK 3.58 per share.
The shares are held through a nominee account in Nordea Luxembourg.
Steen Krøyer's holding after the purchase is 367,200 Bionor shares.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.